BioSpace News Archive

Initiative will raise and distribute funds to local nonprofits serving older adults during the pandemic

Many processes that generate electricity also produce heat, a potent energy resource that often goes untapped everywhere from factories to vehicles to power plants. An innovative system currently being developed at the U.S. Department of Energy’s (DOE) Argonne National Laboratory can quickly store heat and release it for use when needed, surpassing conventional storage options in both flexibility and efficiency

GlaxoSmithKline (LSE/NYSE: GSK) today announced a multi-year partnership with the Arthritis Foundation to support scientific research, advocacy as well as virtual resources and community connections for the more than 30 million people in America living with osteoarthritis (OA)

In an effort to support the global need for medical ventilators, Minnesota-based Tolomatic has dedicated a team of engineers to the development of highly efficient emergency ventilator concept systems using electric linear actuators. The proposed technologies are the first step in creating innovative emergency ventilators for patients around the world.

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced the closing of its initial public offering of 6,900,000 shares of common stock,

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that the Phase 3 trial evaluating its anti-PD-1 antibody tislelizumab in combination with pemetrexed and platinum chemotherapy for the first-line treatment of patients with non-squamous non-small cell lung cancer

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced actions it is taking in response to the COVID-19 pandemic and announced preliminary financial results for the first quarter 2020.

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, announced it will support a series of virtual education events geared toward clinicians and other wound care and surgical stakeholders during the month of April.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced preliminary unaudited revenue for the quarter ended March 31, 2020, and the withdrawal of its full year 2020 financial guidance issued on February 25, 2020.

B. Braun Medical Inc. (B. Braun) today announced that the US Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) of B. Braun’s Perfusor® Space Syringe Infusion Pump, Infusomat® Space Volumetric Infusion Pump, and Outlook® ES Pump systems